theralase_logo_destroying_cancer.png
Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine
February 07, 2022 07:00 ET | Theralase Technologies Inc.
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
theralase_logo_destroying_cancer.png
Theralase Expands Intellectual Property Portfolio
December 09, 2021 07:00 ET | Theralase Technologies Inc.
TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
theralase_logo_destroying_cancer.png
Theralase Releases 3Q21 Financial Statements and Newsletter
November 29, 2021 18:00 ET | Theralase Technologies Inc.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Study II Clinical Data (Preliminary)*
Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter
August 30, 2021 18:15 ET | Theralase Technologies Inc.
TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), A clinical stage pharmaceutical company dedicated to the research...
theralase_logo_destroying_cancer.png
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
June 11, 2021 07:00 ET | Theralase Technologies Inc.
TORONTO, June 11, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Theralase Releases Q12021 Interim Financial Statements
May 28, 2021 18:58 ET | Theralase Technologies Inc.
TORONTO, May 28, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Theralase CEO to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM
March 12, 2014 07:05 ET | Theralase Technologies Inc.
TORONTO, ON--(Marketwired - Mar 12, 2014) - Theralase Technologies Inc. (OTCBB: TLTFF) (TSX VENTURE: TLT) sells patented, superpulsed laser technology to healthcare practitioners to heal damaged...